Please login to the form below
Sharp
This page shows the latest Sharp news and features for those working in and with pharma, biotech and healthcare.
MSD wins key EU approval for Keytruda, Alimta combo
Marking a first in Europe, Merck Sharp &Dohme (MSD)'s Keytruda can now be used in the three-way combination, becoming the first to be approved as a first-line use
Latest news
-
UDG Healthcare sells Aquilant after share drop
Proceeds from the transaction will be funding the continued development of the group’s high-margin divisions, Ashfield and Sharp. ... Sharp also delivered similar results, presenting double digital operating profit growth ahead of the same quarter last
-
New cancer drugs can’t quite plug the revenue hole at AZ
Chief executive Pascal Soriot said the company’s “rich pipeline and sharp commercial focus make us confident that we have in place the right conditions for our return to growth this
-
UDG Healthcare acquires two New-York-based healthcare agencies
The Dublin-headquartered company operates across three divisions – Ashfield, Sharp and Aquilant – and currently employs 9, 000 people with operations in 24 countries.
-
Brexit fears grow for small-to-medium pharma
The new survey of 50 respondents shows sentiment has shifted, with a sharp increase in those saying “We do not have any expectation,” up to 26% from 18% last time.
-
NICE says OK to Keytruda for bladder cancer via the CDF
Becomes the first immunotherapy recommended for UC after chemotherapy. Certain bladder cancer patients in England will be able to get access to Merck Sharp and Dohme’s (MSD) blockbuster Keytruda (pembrolizumab)
More from news
Approximately 1 fully matching, plus 192 partially matching documents found.
Latest Intelligence
-
China: AstraZeneca’s new engine for growth and innovation
That was a sharp increase from last year’s growth of 15% and 16% respectively, and AZ is now recording $1bn in revenue per quarter in the country.
-
A rare talent
The affordability question. Winter, with its flu crises and bed shortages, brings the UK's healthcare spending into sharp relief, but the affordability question facing the NHS isn't a seasonal
-
Turning the tide on change
results. Louise Sharp is founder and managing director of Makara Health Communications and Makara Training Academy.
-
Oral biologics delivery still elusive
As the intestines don't have sharp pain receptors the delivery goes unnoticed by the patient and - according to the company - the lesion caused in the lining of the GI tract
-
Counting down to the EFPIA Disclosure Code
The image of a sharp suited drugs salesman sprinkling largesse on a greedy flock has been banished but old stereotypes could be reignited if the process is not fully explained, EFPIA
More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest appointments
-
Ashfield, Health Unlimited and Ashley Communications add to their teams
He has also served as the executive director for primary care, general medicine at Merck Sharp &Dohme (MSD).
-
Editas Medicine adds to its board of directors
Dr Hopfield has more than two decades worth of experience in the medical and healthcare fields and she has held management positions at Merck Sharp &Dohme ( MSD) in clinical development, outcomes
-
Makara Health appoints Louise Finke as a director
Louise Sharp, founder and managing director of Makara Health, said: “Finke’s considerable experience, strategic approach and industry knowledge make her a perfect fit for Makara as the company continues to
-
Storm Therapeutics bolsters its team
Dr Paul Leeson also joins the University of Cambridge spin-out, following 35 years’ experience of drug discovery and development in senior roles in pharmaceutical companies including GlaxoSmithKline, Merck Sharp and
-
Andy Busch joins Shire as its CSO and head of research and development
populations,”. “This is a unique time to join Shire, as it has built an industry-leading pipeline of rare disease programmes in recent years and has a sharp focus on serial
More from appointments
Approximately 0 fully matching, plus 25 partially matching documents found.
Latest from PMHub
-
What Pharma can learn from B2B digital trends
This is also transforming what sales organizations look like, with a sharp reduction in field sales and marketing, and rapid growth in inside sales and analytics teams.”.
-
How to create an ethical pharma exhibition stand
liquids, sharp objects, etc.) At Apex, our exhibition team has come up with a huge range of alternative and cost-effective gifts to help our clients to stand out from the
-
HSJ Partnership Awards will showcase pharma’s inspirational joint working projects with the NHS
This follows the success of its inaugural programme earlier this year where Merck, Sharp and Dohme were recognised for Best Pharmaceutical Partnership with the NHS for their role in the NHS
-
Digital trends in B2B sales - how far behind is Pharma?
This is also transforming what sales organizations look like, with a sharp reduction in field sales and marketing, and rapid growth in inside sales and analytics teams.”.
-
Training the next generation of biotech leaders
In June 2016 the UK voted to leave the EU, prompting a new direction for Britain’s industrial strategy and a sharp focus on biotech and life sciences – fuelled by leading
More from PMHub
Approximately 0 fully matching, plus 29 partially matching documents found.
Featured jobs
-
Account Director
-
Competitive Salary Offered
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
- Business Development Director – Health Education
-
excellent commission
- Principal Health Economist - North-West
-
Negotiable
-
Medical (Scientific) Director
-
£120, 000 benefits
-
Account Manager
-
Negotiable
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
- Account Manager- Healthcare Advertising
-
Negotiable
-
Medical Writer
-
Salary TBC
-
Associate Director
-
£75, 000-90, 000
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Account Manager- Healthcare Advertising
-
Negotiable
Subscribe to our email news alerts
- FDA clears Sandoz and Pear’s Opioid Use Disorder app
- As May delays, industry warns again of ‘no-deal’ Brexit
- Clark Health Communications and Egg digital announce new collaboration
- Axovant drops last ‘legacy’ drug to focus on gene therapies
- Healthcare excellence celebrated at 2018 HSJ Awards
- Better together when buying medicines? Taking stock of the BeNeLuxA initiative
PMHub
Hamell
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...
Latest intelligence
- Report: Achieving launch excellence in the challenging healthcare markets of today
- Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
- What is blockchain and why should i care - Richard Springham
- Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
- NHS medicines optimisation milestone
- Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...
Quick links
Infographics
